NCT01399450View on ClinicalTrials.gov

Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2016

Study Completion Date

November 30, 2016

Conditions

Schizophrenia

Interventions

DRUG

paliperidone

paliperidone augmenting on ongoing medication

Trial Locations (2)

410-773

Dongguk University International Hospital, Goyang-si

Unknown

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

Johnson & Johnson

All Listed Sponsors

collaborator

Johnson & Johnson

INDUSTRY

lead

Seoul National University Hospital

OTHER